John Theurer Cancer Center at Hackensack University Medical Center

Providing Extraordinary Care

John Theurer Cancer Center

One of the Nation’s Top 50 Cancer Centers

For the past 25 years, John Theurer Cancer Center

at Hackensack University Medical Center has

become one of the largest and most comprehensive

cancer centers in the United States. Today, we are

a top-50 U.S. News & World Report Best Hospitals

for Cancer – the only cancer center in New Jersey

with this prestigious designation.

jtcancercenter.org201-996-5900

A Message from Dr. Pecora and Dr. Goy AttheJohnTheurerCancerCenter,webelievecancerishardenoughforpatientsandtheirlovedones.Itisthisbeliefthatdrivesourpassiontodeliverextraordinarycareeveryday,helpingusbecomeoneofthenation’stop50cancercenters–theonlycancercenterinNewJerseywiththisrecognition.

Overthepast25years,wehavebecomeoneofthelargestcancercentersintheUnitedStates,butwehavekeptourfocusontheuniqueneedsofthepatientswhoplacetheirtrustinourdoctorsandstaff.Prevention,treatment,andresearchadvanceshavegrownexponentiallyoverthose25years.Wearenotonlykeepingupwiththechangeofpace,weareattheforefrontofdeliveringinnovativecare,andprovidingtomorrow’streatmenttodayby:

• Taking multidisciplinary care to a new levelwithteamsofdisease-specificexpertsunderoneroof• Delivering personalized medicinefocusedonnoveltherapies,participatorytreatment,predictive

measures,andpreventivecare• Advancing researchthroughbiomarker-drivenclinicaltrialsandtranslationalresearch• Providing holistic carethatincludesawiderangeofcomplementaryservicesimportanttothe

well-beingofourpatientsthatcanbeeasilyintegratedintotheircare• Creating a comforting environmentinanewhigh-tech,high-touchbuilding

Webelieveourmodelisthenextsteptowardthefutureofpatientcare.Inthepagesthatfollow,weinviteyoutoseehowtheJohnTheurerCancerCenterischangingthecancercareexperienceonepatientatatime.

Sincerely,

Andrew Pecora,M.D.,F.A.C.P.,C.P.E.ChiefInnovationsOfficer,ProfessorandVicePresidentofCancerServices,JohnTheurerCancerCenteratHackensackUniversityMedicalCenter

Andre Goy,M.D.,M.S.ChairmanandDirector,ChiefofLymphoma,andDirector,ClinicalandTranslationalCancerResearch,JohnTheurerCancerCenteratHackensackUniversityMedicalCenter

message

Innovative Care in a Patient-Centered EnvironmentThelobbyfeaturesaflightof200soaringMuranoglassblownbirdsandaninspiringLivingWallmadeofover30plantspecies,allhydroponicallygrowingwithoutsoilandaccompaniedbya24-footwaterfall.Thewallbreaksdownindooraircontaminatesthroughentirelynaturalprocesses,releasingpurer,cleanerair.

Otherresourcestohelppatientsandcaregiversintheirfightagainstcancerinclude:

• Tranquility/meditationroom,fitnessstudio,andyogaclassesthatarefreeforpatients

• Terracegardenwithavegetablegardentoteachcancerpatientshowtogrowtheirownfood

• Patientresourcelibrarywithamedicallibrarianandcybercafétostayconnected

• Demonstrationkitchenforcookingandnutritionlessons

jtcancercenter.org

A New Building to Deliver Extraordinary CareInJanuary2011,weopenedanewbuildingthatnowhousesour14specialtydivisionsalongwithourresearchandoncologyservices.Thisprovidesourpatientswithanunparalleledexperiencethroughinnovativeapproachesincomfortablesurroundings.

facilities

John Theurer Cancer Center Practice SpecialtiesWe are comprised of 14 specialized divisions and Radiation Oncology experts. Division Chiefs are supported by medical, research, nursing, nutrition, and psychosocial support for more advanced, focused care for patients.

Blood and Marrow Stem Cell Transplantation Program

Lymphoma Division

Multiple Myeloma Division

Leukemia Division

Neuro-Oncology Division: Brain and Spine Institute

Skin and Sarcoma Division: Cutaneous Malignancy Program

Gastrointestinal Oncology Division

Geriatric Oncology Division

Head and Neck Oncology Division

Thoracic Oncology Division

Radiation Oncology Department

Urologic Oncology Division

Breast Oncology Division

Gynecologic Oncology Division

Research Division

specialtiesspecialtiesspecialtiesspecialtiesspecialties

• ParticipatesingroundbreakingresearchfundedbytheSusanVaughanFoundationforTranslationalResearchinLymphoma,theFDA,andseveralpharmaceuticalcompanies.

• Dr.Goyiswidelyknownforhisworkasco-principalinvestigatoronthePINNACLEtrial,whichledtotheFDA’sapprovalofVELCADE®(bortezomib)foradefinedgroupofmantlecelllymphomapatients.

• Dr.GoytookpartintheoriginalpilotstudyforRITUXAN®(rituximab),whichdoctorshavewidelyusedtotreatlymphomas,leukemias,andautoimmunedisorders.

• Dr.GoyisamemberoftheLymphomaResearchFoundation’sScientificAdvisoryBoard,whichiscomprisedoftheworld’sleadinglymphomaresearchersandoncologists.

• CollaborateswiththeLymphomaResearchFoundationtopresentthelatestpracticesinthediagnosisandmanagementoflymphoma.

Lymphoma Andre Goy,M.D.,M.S.,ChairmanandDirector,Chief,LymphomaandDirector,ClinicalandTranslationalCancerResearch

Tatyana Feldman,M.D.,Attending,Lymphoma

Anthony Mato,M.D.,Attending,Lymphoma

Pritish Bhattacharyya,M.D.,Pathology,Lymphoma

Kar Chow,M.D.,Pathology,Lymphoma

Xiao Yang,M.D.,Ph.D.,Pathology,Lymphoma

Anthony Ingenito,M.D.,Chairman,RadiationOncology

LedbyinternationallyrenownedclinicianandresearcherDr.Goy,theLymphomaDivisionisdedicatedtotreatingcancersofthelymphaticsystem,includingHodgkinlymphomaandnon-Hodgkinlymphomaandseriousblooddisorderssuchasamyloidosis.

Hematological Malignancies Our clinicians are leading some of the most significant research for blood-borne cancers today. In 2010, we presented research updates and clinical trial results of 40 cutting-edge studies at the annual American Society of Hematology Meeting, including multicenter, international trials in collaboration with leading cancer institutions, such as the National Cancer Institute (NCI), MD Anderson, Dana-Farber, Mayo Clinic, and Memorial Sloan-Kettering.

• Morethan30clinicaltrialsunderway,includingmulticenterstudiesincollaborationwiththeNCIandNationalMarrowDonorProgram.

• PartoftheBoneMarrowTransplantClinicalTrialsNetworkandEasternCooperativeOncologyGroup,allowingustocollaborateonnationalclinicaltrials.

• Clinicaltrialscovermultipleareas:leukemia(AML,ALL,CLL,CML),plasmacelldyscrasias(myeloma,amyloidosis,Waldenstrom’s),

lymphoma(non-Hodgkin,Hodgkin)aswellasmyelodysplasticandmyeloproliferativedisordersandhemoglobinopathies(sicklecellanemia).

• Extensiveexperienceinstemcelltransplanttherapyformultiplemyeloma.

• Performsmorephotopheresisproceduresthananytransplantationprograminthecountry.

Blood and Marrow Stem Cell Transplantation Scott Rowley,M.D.,F.A.C.P.,Chief,BloodandMarrowStemCellTransplantationProgram

Michele Donato,M.D.,MedicalDirector,BloodandMarrowCollectionFacility

David Vesole,M.D.,Ph.D.,Co-ChiefandDirector,Research,MultipleMyeloma

Andrew Pecora,M.D.,F.A.C.P.,C.P.E.,ChiefInnovationsOfficer,ProfessorandVicePresidentofCancerServices

Oneofthenation’s10largestadultBloodandMarrowStemCellTransplantprograms,performingmorethan300transplantslastyearandmorethan4,000total.

• ActiveinclinicaltrialsthatledtoFDAapprovalofGLEEVEC®(imatinibmesylate)andanewindicationforTasigna®(nilotinib).

• Dr.Goldbergisinternationallyrecognizedforhisresearchinleukemiaandotherbloodcancers.InApril2010,heledresearchpublishedintheJournalofClinicalOncology,whichconcludedmyelodysplasticsyndromesbloodcancerisfivetimesmorecommonthanpreviouslythought.

• Partnerswithmultiplepatientsupportsgroups,suchastheLeukemia&LymphomaSociety,tohosteducationaleventsandtoprovideimportantprogramsforpatientsandtheirlovedonesaswellasforhealthcareprofessionals.

Leukemia Stuart Goldberg,M.D.,Chief,Leukemia

Pritish Bhattacharyya,M.D.,Pathology,Leukemia

Kar Chow M.D.,Pathology,Leukemia


TheLeukemiaDivisionusesavarietyoftreatmentoptions,includingchemotherapyandstemcelltransplantation,toensurepatientsreceivethebestcareavailable.

“When I was diagnosed with multiple myeloma, they told me I had up to

three years to live. Thanks to access to the latest clinical trials and great

personnel, I have spent the last 17 years traveling the world and

watching my grandchildren become adults.”

—George Chambers, 17-year multiple myeloma survivor

• MemberoftheMultipleMyelomaResearchConsortium(MMRC),auniqueresearchmodelconsistingof16institutionstoacceleratethedevelopmentofnovel,cutting-edgemultiplemyelomatreatments.

• Dr.SiegelandDr.Vesolearetwooftheforemostinternationalauthoritiesinmultiplemyeloma,frequentlypublishedintop-tierpeer-reviewedmedicaljournalssuchasJournalofClinicalOncology,Blood,LancetOncology,andTheNewEnglandJournalofMedicine.

• Participatedinlandmarkresearchthathasledtotheapprovalofsomeofthemostsignificantmultiplemyelomatherapiesused

today,includingVELCADE®(bortezomib),REVLIMID®(lenalidomide),Pomalidomide,andCarfilzomib.

• Ourresearchersjoinedcolleaguesfrom20institutionstopublishthefirstcompletegenomicportraitofmultiplemyeloma.

• Aleaderininnovativestemcelltransplantmodalitiesforthetreatmentofmultiplemyeloma.

Multiple Myeloma David Siegel,M.D.,Ph.D.,Chief,MultipleMyeloma

David Vesole,M.D.,Ph.D.,Co-ChiefandDirector,Research,MultipleMyeloma

Joshua Richter,M.D.,Attending,MultipleMyeloma

OneofthefewfacilitiesintheU.S.toprovidespecializedexpertiseinmultiplemyeloma,primarysystemicamyloidosisandWaldenstrom’smacroglobulinemia,offeringnewandemergingtherapiesthatenhancethequalityandextendthelifeofpatientswithplasmacelldisorders.

Multiple MyelomaResearch Consortium

Powerful Collaboration Accelerates Results

“I would have gone anywhere to get the best possible treatment, but I found

it right here in Hackensack. My friends and family didn’t have to travel into

New York City during my lengthy hospital stay and the care I received was first-rate.”

—Julie Mott, leukemia survivor and 8th person in the world to survivealivertransplantandstemcelltransplant

• OneofthelargestsurgicalmelanomapracticesinNewJersey,conductingmorelymphaticcasesthananyotherinthestate.

• OneoftheonlycancercentersinNewJerseywithadermatopathologistonthestaff.

• ExtensiveexpertiseinMohsmicrographicsurgery,aspecializedprocedurethathasthehighestcurerateofallsurgicaltreatmentsforbasalcellandsquamouscellcarcinoma.

• InvolvedinthelandmarkstudythatledtotheFDA’sfasttrackandapprovalofYERVOY™(ipilimumab),abreakthroughtreatmentformetastaticmelanoma.

• Extensiveexperienceinlimb-sparingsurgeryforshouldergirdletumors,cryosurgery,radiofrequencyablation,andminimallyinvasivebiopsies.

Skin and Sarcoma: Cutaneous Malignancy Program Andrew Pecora,M.D.,F.A.C.P.,C.P.E.,ChiefInnovationsOfficer,ProfessorandVicePresidentofCancerServices,andChief,CutaneousMalignancyProgram

Donald McCain,M.D.,Ph.D.,ViceChairmanandChief,SurgicalOncology,CutaneousMalignancyProgram

James Wittig,M.D.,Chief,SarcomaCancerandChief,OrthopedicOncology

Robin Ashinoff,M.D.,Chief,Dermatologic,MohsandLaserSurgery

Richard Winters,M.D.,F.A.C.S,Vice-Chairman,PlasticandReconstructiveSurgery


ProvidesamultidisciplinaryteamofleadingexpertsinMohssurgery,dermatopathology,dermatology,medicaloncology,oncologicsurgery,radiationoncology,reconstructivesurgeryandresearch.Ourprogramtreatsallstagesofmalignantmelanoma,squamouscellcarcinoma,basalcellcarcinoma,andothercutaneousmalignancies.

“I was diagnosed with a brain tumor when I was four months pregnant.

It wasn’t certain that the entire tumor could be removed, but Dr. Kaptain took on

my case and I’ve been in remission for five years. It is nothing short of a miracle.”

—AntoniaReyes,braincancersurvivor

• Ledbyneuro-oncologistDr.Goldlust,whorecentlyjoinedfromMemorialSloan-KetteringCancerCenterandneurosurgeonDr.Kaptain,whohassubspecialtytrainingbothinneuro-oncologyandskull-basesurgery.

• Multidisciplinaryteamincludesexpertsinneurology,neurosurgery,medicaloncology,radiationoncology,behavioralhealth,neuroradiology,otolaryngology,pathology,andnursing.

• Researchisfocusedupondevelopingnoveltherapeuticsforprimaryandmetastaticbraintumors,improvingcarefortumor-relatedepilepsy,anddevelopingstrategiesforneuro-protectionincancerpatients.

• Oneofonly20facilitiesintheU.S.toofferMRI-guidedlaserinterstitialthermaltherapy,anoveltechnologythatallowsforprecisionremovaloftumorsthatmayotherwisebeinoperable.

• Advancedimagingcapabilitiesincludediffusiontensorimaging,anMRItechniquethatallowsprecisionmappingofneuralpathwaysinthebrain.Withthisandotherrelatedimagingmodalities,ourphysiciansareabletominimizeharmtonormaltissuesduringtreatment.

• TheAnnualNeuro-OncologySymposiumbringstogetherworldrenownedexpertstodiscussrecentbreakthroughsandtrendsinthefield.

Neuro-Oncology: The Brain and Spine Institute Samuel A. Goldlust,M.D.,Co-Chief,TheBrainandSpineInstitute

George Kaptain,M.D.,Co-Chief,TheBrainandSpineInstitute

Hooman Azmi,M.D.,Neurosurgeon,TheBrainandSpineInstitute

Mark Pascal,M.D.,Neuro-oncologist,TheBrainandSpineInstitute

David Panush,M.D.,SectionHead,Neuroradiology,DiagnosticRadiology


In2011,theJohnTheurerCancerlaunchedtheBrainandSpineInstitutetocoordinatemulti-disciplinarycuttingedgecareandresearchforprimaryandmetastaticbraintumorsaswellastheneurologicalcomplicationsofcancer.

• Bringstogetherexpertsinotolaryngology(ear,nose,andthroatmedicine),plasticandreconstructivesurgery,medicaloncology,maxillofacialsurgery,dentistry,radiationoncology,radiology,andnursing.

• HostsannualHeadandNeckCancerForumthatprovidessupport,networking,andinformation.

• Activeresearchinradiationapproachestoimproveoutcomesandqualityoflifeforheadandneckcancerpatients.

Head and Neck Oncology Loren Godfrey, M.D., Co-Chief, Head and Neck Oncology and Director, BrachytherapyBrian Benson, M.D., Co-Chief, Head and Neck Oncology

Our specialized team is dedicated to preventing, diagnosing, treating, and managing cancers of the head andneck,includingcancersofthemouth,throat,tongue,thyroid,andsinuses.

• OneofthemostactivethoraciconcologyclinicaltrialsitesinNewJersey.

• Internationallyrecognizedleadersinminimallyinvasivesurgicalapproachestothoraciccancertreatment.

• Dr.Parkisoneoftheoriginalinnovatorsinroboticvideo-assistedthoracicsurgery(VATS)

lobectomy,aminimallyinvasiveprocedurethatcandecreaserecoverytime,usingthedaVinci™surgicalsystem.

• Employingadvanceddiagnostictechniquessuchasendobronchialultrasound(EBUS)andnavigationalbronchoscopy.

Thoracic Oncology Bernard Park,M.D.,Co-Chief,ThoracicOncologyHarry Harper,M.D.,Co-Chief,ThoracicOncologyAnthony Ingenito,M.D.,Chairman,RadiationOncology

OneofonlyahandfulofcancercentersinNewJerseywithafull-timemultidisciplinarythoraciconcologyteam,specializinginthediagnosisandtreatmentoflungcancer,esophagealcancer,malignantmesothelioma,mediastinaltumors,andothercancerswithinthechest.

• ExtensiveexpertisewiththedaVinci®roboticsurgerysystemforminimallyinvasive,precisesurgeries.

• Endoscopicultrasoundforearlydetectionofgastrointestinaldiseases.

• Expertsinlaparoscopicliverresections,asurgicaltechniquethatallowspatientstogo

homeearlierandrecoverfastercomparedtoopenprocedures.

• Openandroboticcolonresections,whereapartortheentirecolonisremoved.

• Extensiveexperiencetreatingprimaryandmetastaticlivertumorswithhepaticresectionsandradiofrequencyablation.

Gastrointestinal Oncology Andrew Jennis,M.D.,Co-Chief,GastrointestinalOncology

Donald McCain,M.D.,Ph.D.,F.A.C.S.,ViceChairmanandCo-Chief,GastrointestinalOncology


Ourteamofmorethan20expertsingastroenterology,surgery,medicaloncology,radiationoncology,radiology,pathologyandnursingisdedicatedtocancersofthegastrointestinalsystem.Ourteamoffersinnovativetreatmentsandsurgicalapproachestoimproveoutcomesanddecreaserecoverytime.

• Afocusontheuniqueneeds,treatment,andrecoveryofpatientsage65andolder.

• Operatesanactivepain-managementprogramandextensivepalliativecareservicesthataddressend-of-lifeissuesandattempttoeasepainanddiscomfortforpatients.

Geriatric Oncology Richard Rosenbluth,M.D.,Chief,GeriatricOncology

ThisisthefirstdedicatedprogramdesignedforseniorcancerpatientsinNewYorkandNewJersey.

• Usesthemostadvanceddiagnosticandtreatmentmethodsavailable,includingminimallyinvasive,laparoscopic,TomoTherapy®,roboticsurgicalprocedures,andcryosurgery.

• FirstcancercenterinNewJerseytoofferthecompletecapabilitiesofbreakthroughimmunotherapyProvenge®(sipuleucel-T)treatment.Prostatecancerpatientscanreceiveacell-collectionprocessandinfusionbyasingleteam,allowingforamoreintimate,comfortingcourseoftreatment.

• Thelargest high-dose-rate(HDR)brachytherapycenterinthetri-statearea, whichallowsphysicianstodeliverpreciseradiationtreatmentdirectlytoatumors.

• MostexperiencedTomoTherapy® radiation centerinNewJerseyforprostatecancer,whichis oneofthemosteffective radiation methodsfortargetedprostatecancertreatment.

• Roboticsurgerytrainingsiteforthenortheast.

• RankednumberoneinNewJerseybyHealthgradesforprostatectomy.

• Activeinclincialtrialsforprostate,renalandbladdercancer.

Urologic Oncology Ihor Sawczuk,M.D.,Co-Chief,UrologicOncologyandChairman,DepartmentofUrology

Robert Alter,M.D.,Co-Chief,UrologicOncology

Glen Gejerman,M.D.,Co-Chief,UrologicOncologyandDirector,RadiationOncology

Thismultidisciplinaryteam,whichincludessomeofworld’sleadersinurologiconcology,isdedicatedtocancersofthegenitourinarysystem,includingkidneys,adrenalglands,ureters,bladder,prostategland,testes,andmalegenitalia.

“The yoga classes have helped improve my breathing, relaxation, and flexibility.

More importantly, it shows me that the doctors and staff don’t just want to

treat my cancer – they truly care about my total well-being.”

—Bimla Shukla, breast cancer patient

• Amultidisciplinaryteamincludingboard-certifiedradiationoncologists,medicalphysicists,technologists,radiationtherapists,medicaldosimetrists,certifiedmedicalassistants,socialworkers,andregistereddietitians.

• AccreditedbytheAmericanCollegeofRadiationOncology.

• Safetyprogramrankedabovethe95thpercentilebytheAmericanCollegeofRadiology,andpatientsatisfactionscoresarealsorankedinthe95thpercentileorgreatercomparedtopeers.

• FirstcancercenterinNewJerseytoacquireTrueBeam™,whichenablesaradicallydifferentapproachtotreatingcancerwithimage-guided

therapy,andtheonlycancercenterinthecountrytoacquiretwomachines.

• MostexperiencedcancercentertoofferTomoTherapy®,treatingprostate,lung,andheadandneckcancerwithunparalleledaccuracy,precision,andsafety.

• Activeinclinicaltrials,withresearchinnewapproachessuchasbrachytherapy,DoseVerificationSystem®(DVS),andTomoTherapy®.

• Implantsabreakthroughradiationmeasurementtechnology,knownasDVS®,whichprovidesdataontheamountofradiationdeliveredtotumorsandsurroundingtissue.

• Above-groundradiationfacility.

Radiation Oncology Anthony Ingenito,M.D.,Chairman,RadiationOncology

Glen Gejerman,M.D.,Co-Chief,UrologicOncologyandDirector,RadiationOncology

Loren Godfrey,M.D.,Co-Chief,HeadandNeckandDirector,Brachytherapy

Providesthemostadvancedradiationtherapytreatmentmethodsandadedicatedteamofon-siteradiationoncologistswithdisease-specificexpertise.

• Accesstomultipleclinicaltrialsinovarian,uterine,andcervicalcancers,includingnationaltrialsledbytheGynecologicOncologyGroup,acooperativecancerresearchgroupfundedbytheNCI.

• Oneofonly20centersinthecountryselectedtotrainphysiciansfortherevolutionarydaVinci®surgicalrobot,whichmakesgynecologiccancersurgeryeasierandsafer.

• Expertsinminimallyinvasivesurgicaloptions,includinglaparoscopicandroboticsurgery.

• Oneoffewcentersskilledinbothintracavitaryandinterstitialhigh-dose-rategynecologicbrachytherapytechniques–advancedcancertreatmentsthatdeliverpreciseradiationdirectlyintotumors,typicallyonanoutpatientbasis.

Gynecologic Oncology Donna McNamara,M.D.,Co-Chief,GynecologicOncology

Babak Litkouhi,M.D.,Co-Chief,SurgicalGynecologicOncology

Ami Vaidya,M.D.,Director,GynecologicRoboticSurgery

Loren Godfrey,M.D.,RadiatonOncologist,GynecologicOncology

TheGynecologicOncologyDivisionprovidesourfemalepatientswithextraordinarycarefromleadingphysicianswhounderstandtheuniquechallengesofwomenbattlingcancer.

TheMaureenFundisacommunity-educationoutreachprogramthatprovidesovariancancerscreeningsandpreventionservicesforwomen.

• Accesstomultipleclinicaltrialsin breastcancer,includingnationaltrialsledbytheCancerandLeukemiaGroupBandEasternCooperativeOncologyGroup,aswellasaccesstonewPhaseIdrugs.

• OneofthelargestclinicaltrialsitesforHerceptin®(trastuzumab),adrugthatchangedthelandscapeforbreastcancercare.

• OfferspartialbreastirradiationusingMammoSite®targetedradiationtherapy,whichreducestreatmentfromsixweekstofivedaysformanypatients.

• Eachyear,weinviteleadingbreastoncologiststopresentthelatestresearchfindingstophysiciansandhealthcareprofessionalssotheycanapplytheselearningstotheclinic.

Breast Oncology Stanley Waintraub,M.D.,Co-Chief,BreastOncology

Mary Jane Warden,M.D.,ActingCo-Chief,BreastOncology

Loren Godfrey,M.D.,RadiatonOncologist,BreastOncology

OurBreastOncologyDivisionisoneofonlyahandfuloffacilitiesinNewJerseytoofferthemostinnovativetreatmentoptionsdeliveredbyanintegrated,prominentlytrainedgroupofhighlyspecializedbreastcancerexperts.

Women’s Health Oncology Services We offer a depth of expertise that has propelled our women’s health center to a leadership role in the national fight against cancers specific to women.

TheAngelsofHopeFoundationhascreatedacomfortingenvironmentontheWomen’sHealthfloor,withabeautifulwaitingareatohelppatientsfeelateasepriortotheirappointments.Theirgenerousdonationsalsoprovideservicesforwomenwithcancerwhootherwisecouldnotaffordthem.

www.aoh-nj.org

Extraordinary Care Means Cutting-Edge Research Andre Goy, M.D., M.S., Chairman and Director, Chief, Lymphoma and Director, Clinical and Translational Cancer Research

Robert Korngold, Ph.D., Chairman, Research

Martin Gutierrez, M.D., Director, Drug Discovery/Phase 1 Unit

We have been conducting bench to bedside research for more than two decades. Today, a large part of our research is supporting personalized medicine and targeted therapies that we believe can help researchers and clinicians improve outcomes. We have established relationships with cooperative research groups and the pharmaceutical and biotech industry to help bring innovative and translational drugs from Phase I and Phase II trials into the clinic for the benefi t of our cancer patients and patients around the globe.

• More than 200 open, actively enrolling clinical trials and a strong translational research program.

• Leading multicenter, international trials in collaboration with other cancer institutions, such as the NCI, MD Anderson, Dana-Farber, Mayo Clinic, and Memorial Sloan-Kettering.

• More than 120 peer reviewed publications published in the last four years to advance cancer research.

• Part of the Bone Marrow Clinical Trials Network, Eastern Cooperative Oncology Group, and Multiple Myeloma Research Consortium allowing us to collaborate on national clinical trials.

• One of few sites in New Jersey to offer molecular staging and classifi cation capabilities.

• Phase I Clinical Oncology program with an outpatient clinic and a dedicated inpatient bed facility.

• The Tumor Bank has collected more than 2,000 high-quality specimens to advance cancer research.

• Participates in a unique partnership with the National Cancer Institute to establish a joint clinical research program to develop innovative immunology-based translational research approaches around bone marrow transplantation.

• Immunology laboratory leads cutting-edge stem cell research focused on improving allogeneic bone marrow transplant by mitigating the effects of Graft vs. Host Disease.

• Clinical trial site for many breakthrough therapies, such as VELCADE® (bortezomib), GLEEVEC® (imatinib mesylate), Tasigna® (nilotinib), Provenge® (sipuleucel-T), Herceptin® (trastuzumab), Avastin® (bevacizumab), YERVOY™ (ipilimumab).

research

Search For Clinical Trials

jtcancercenter.org/[email protected]

John Theurer Cancer Center at Hackensack University Medical Center

92 Second Street, Hackensack, NJ 07601 • 201-996-5900

jtcancercenter.org

Celebrating Life and Liberty Everyyear,wecelebratewithallofourpatientsandtheirlovedonesatLibertyStatePark.ThisSeptember,morethan2,200peoplejoinedusandwehopethiscelebrationcontinuestogrow.

“The John Theurer Cancer Center gave me personal attention and made me a part of the treatment team

– they didn’t just treat me as another statistic.”

—SusanWinton,pancreaticcystadenomasurvivor

jtcancercenter.org 201-996-5900Join JTCancerCenter Online

©2011

John Theurer Cancer Center at Hackensack University Medical Center

Documents

Transcript of John Theurer Cancer Center at Hackensack University Medical Center